BIOLOGICAL · Unmapped registry intervention
Globo-H-GM2-Lewis-y-MUC1-32(aa)-sTn(c)-TF(c)-Tn(c)-KLH conjugate vaccine
Find medicine records ·
Find other trials using this name
Clinical trial
Vaccine Therapy in Treating Patients at High Risk for Breast Cancer Recurrence
NCT00030823
Drugs and interventions used in this trial
2 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
BIOLOGICAL · Unmapped registry intervention
QS21
Find medicine records ·
Find other trials using this name
No matching interventions in this trial.
Study at a glance
Registry-backedVaccine Therapy in Treating Patients at High Risk for Breast Cancer Recurrence
Design: INTERVENTIONAL · Status: COMPLETED · Phase: NA
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Breast Cancerverified · MONDO: breast cancer
Interventions
QS21BIOLOGICAL
Sponsors & collaborators
Memorial Sloan Kettering Cancer Centerlead sponsor
National Cancer Institute (NCI)collaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT00030823 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.